抗胆碱能药物负荷与认知及躯体损害的关联:InCHIANTI研究结果
该回顾性队列研究纳入1453名20-102岁成人,评估抗胆碱能药物负荷(ACB)与认知损害、躯体衰弱及认知衰弱的关联。结果显示ACB与认知下降(p=.02)、衰弱(p<.001)及认知衰弱(p<.001)显著相关,且ACB是这些表型的较强预测因素(AUC 0.81-0.88)。结论认为抗胆碱能药物是潜在可干预的危险因素。
要点
- ACB与认知损害、衰弱及认知衰弱均显著相关。
- ACB每增加单位,认知损害、衰弱、认知衰弱风险分别增加21%、33%、36%。
- ACB对三种表型的预测AUC为0.81-0.88,属较强预测因素。
核心结论
- 抗胆碱能药物负荷是认知损害、躯体衰弱和认知衰弱的显著相关因素,且为潜在可干预的危险因素。
研究设计与样本
- 回顾性队列研究,纳入1453名20-102岁成人,采用横断面分析、logistic回归、有序回归及极端梯度提升进行预测建模。
主要发现
- ACB与认知下降显著相关(p=.02)。
- ACB与衰弱显著相关(p<.001)。
- ACB与认知衰弱显著相关(p<.001)。
- 认知损害比值比增加1.21(95%CI 1.06-1.37,p<.001)。
- 衰弱比值比增加1.33(95%CI 1.18-1.50,p<.001),认知衰弱比值比增加1.36(95%CI 1.21-1.54,p<.001)。
关键数值与推荐
- ACB对认知损害、躯体衰弱和认知衰弱的预测AUC范围为0.81-0.88。
临床怎么用
- 识别可逆的认知和躯体损害原因对老年人群至关重要,抗胆碱能药物负荷可作为干预靶点。
- 研究结果支持开展针对老年人的处方精简(deprescribing)项目以预防认知和躯体功能下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aims of this study were to evaluate the relationship between anticholinergic drug burden (ACB) cognitive impairment, physical frailty, and cognitive frailty, and to determine if ACB is predictive of these phenotypes when modeled with biological and genomic biomarkers. METHODS: In a retrospective cohort study, a total of 1,453 adults aged 20-102 years were used to examine ACB as a predictor for cognitive impairment, physical frailty, and cognitive frailty. Anticholinergic burden is examined as a predictor for all phenotypes in a cross-sectional analysis using logistic, ordinal regression models, and Extreme Gradient Boosting for population predictive modeling. RESULTS: A significant association was found between ACB and cognitive decline (p = .02), frailty (p < .001), and cognitive frailty (p < .001). The odds of cognitive impairment increased by 1.21 (95% confidence interval [CI] = 1.06-1.37, p < .001), odds of being frail increased by 1.33 (95% CI = 1.18-1.50, p < .001), and odds of having cognitive frailty increased by 1.36 (95% CI = 1.21-1.54, p < .001). Population modeling results indicated ACB score as one of the stronger predictors for cognitive impairment, physical frailty, and cognitive frailty with area under the curves ranging from 0.81 to 0.88. CONCLUSIONS: Anticholinergic medications are a potentially modifiable risk factor for the prevention of cognitive and physical decline. Identification of reversible causes for cognitive and physical impairment is critical for the aging population. These findings encourage new research that may lead to effective interventions for deprescribing programs for the prevention of cognitive and physical decline in older adults.
引用
- Sargent L, Nalls M, Amella EJ, et al. Anticholinergic Drug Induced Cognitive and Physical Impairment: Results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci. 2020. PMID: 30590397. doi:10.1093/gerona/gly289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。